GlassScriptPhysician profile
Bradley A Byergo
NPI 1336272285
$10,027.73
in general payments reported to CMS, 2019-2025
21 companies · $2,604 in 2025
The $2,604 reported for 2025 was more than what 98% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $108 · 2021: $1,155 · 2022: $4,113 · 2023: $693 · 2024: $905 · 2025: $2,604.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,400 · Food and Beverage: $1,621 · Entertainment: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,400.00 |
| Food and Beverage | $1,620.53 |
| Entertainment | $180.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $4,656.54 | 2021-2025 | Precision 1, Dailies |
| Coopervision INC. | $3,193.63 | 2019-2025 | Myday Contact Lens, Onefit Contact Lens, Misight Contact Lens |
| Bausch & Lomb Americas INC. | $519.42 | 2022-2025 | Infuse, Biotrue One Day |
| Abb Con-Cise Optical Group LLC | $229.79 | 2019-2023 | Spectacle Lenses, Contact Lens |
| Optos, INC. | $206.43 | 2022-2025 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Allergan, INC. | $192.78 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $160.25 | 2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $139.03 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $124.43 | 2019 | |
| Abbvie INC. | $104.03 | 2022-2023 | Vuity, Lumigan |
| Sun Pharmaceutical Industries INC. | $100.69 | 2022 | |
| Dompe US, INC. | $92.78 | 2021 | |
| Optovue, INC. | $80.84 | 2019 | |
| Sight Sciences, INC. | $80.48 | 2023 | Tearcare System |
| Lombart Brothers, INC. | $46.76 | 2019-2023 | Opd-III |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lkc Technologies, INC. | $23.24 | 2025 | |
| Oyster Point Pharma, INC. | $22.62 | 2024 | Tyrvaya |
| Maculogix, INC. | $19.60 | 2019 | |
| Johnson & Johnson Vision Care, INC. | $13.17 | 2023 | Acuvue |
| Menicon America INC | $13.10 | 2019 | |
| Biotissue Holdings INC. | $8.12 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Byergo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.